We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils New Guidance, Plans to Boost Access to Generics
FDA Unveils New Guidance, Plans to Boost Access to Generics
FDA Commissioner Scott Gottlieb on Friday announced the release of draft guidance on a new approval pathway for generic drugs and said the agency will roll out new policies over the next year aimed at increasing access to generics and boosting price competition for branded drugs.